−116
Aligos Therapeutics, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
−79.4
FY23:
−79.0
FY24:
−80.7
FY25:
−82.5
Change from FY21 to FY25
millions USD
FY21:
3.02
FY22:
−26.3
FY23:
45.0
FY24:
−18.3
FY25:
−37.8
Change from FY21 to FY25
millions USD
FY21:
78.7
FY22:
0.16
FY23:
88.3
FY24:
0.36
FY25:
102
(positive)
Change from FY21 to FY24
millions USD
FY21:
−117
FY22:
−80.3
FY23:
−79.0
FY24:
−80.9
FY25:
–
All amounts in millions USD